Strategy. Science. Success.
Meet your next partner, discover your next deal, explore your next innovation
The 2026 agenda and speakers will be posted soon.
In the meantime, discover what the expanded program will cover.
Introducing Our Expanded 2026 Program
This year's BIO-Europe program is expanding beyond partnering to deliver a more comprehensive experience across six specialized content tracks. Explore critical insights spanning Dealmaking, Therapeutic Areas, Industry Ecosystem, Regulatory Developments, Clinical Affairs, and Manufacturing Strategy. Whether you're focused on forging partnerships, navigating regulatory pathways, advancing clinical programs, or optimizing manufacturing operations, our expanded agenda offers the strategic knowledge and connections you need to drive innovation forward.
THE BIG PICTURE
The Big Picture provides the strategic context for the issues that drive your commercial decisions. The disruptive big ideas, the geopolitical context re-writing the rule book, the opposing viewpoints that clarify the right path — these are the discussions that will make the future of biotech.
The Business of Biotech
The intersection of capital, strategy, and deal-making. The Business of Biotech track brings together the decision-makers shaping investment flows, M&A activity, and global partnerships across the industry. From shifting capital trends and the rise of AI to the growing influence of Eastern markets, this track is where biotech leaders, investors, and advisors define what’s next.
Key sessions include:
- Voices from the IPO Class of ’25/’26: What’s Next?
- The State of Early-Stage Investment in Biotech
- Scaling Success: The Dynamics of Late-Stage Investment in Biotech
- The 'Unpacking the Deal' Series - fireside chats with some of this year's biggest dealmakers
Regulatory Strategy
The Regulatory Strategy track delves into the fundamental transformation of Europe’s regulatory and innovation ecosystem, exploring how frameworks like the General Pharmaceutical Legislation (GPL) and the Biotech Act, are reshaping the competitive landscape. By drawing comparisons with global regulatory frameworks in key areas, this regulatory track offers actionable insights and suggestions to streamline your regulatory strategy. Join top policymakers, industry leaders, and experts to uncover how regulatory frameworks can become a competitive advantage and drive innovation.
Key sessions include:
- Accelerating Innovation and Market Exclusivity Through Regulatory Incentives
- Mastering the Shifting Regulatory Landscape: Leveraging the Biotech Act for Innovation and Global Success
- AI Regulations: Driving Innovation While Navigating Compliance
Therapeutic Insights
This is where science meets strategy. The Therapeutic Insights track spotlights the most exciting areas of innovation—from neuroscience and rare diseases to women’s health and longevity—and the partnerships and models accelerating them forward. Align your strategy with cutting-edge science and high-value therapeutic areas, while engaging the biotech and pharma leaders driving the next wave of breakthroughs. Discover the science driving breakthrough therapies and the biopharma partnerships that are redefining what is possible.
Key topics include:
- Cardiometabolic innovations beyond GLP-1 – Where are we now?
- Networks or neurons: What’s next in CNS dealmaking?
- Immunology under the microscope: New frontiers
- Radioligand therapy: Where we've progressed and what matters next
Biomanufacturing Strategy
The Biomanufacturing Strategies Track represents a paradigm shift in how the industry approaches manufacturing - positioning it as an early-stage business imperative rather than a late-stage operational concern. This forward-thinking program addresses critical gaps in the evolving biopharma landscape by focusing on innovative approaches, strategic solutions, and collaborative ecosystems that optimize processes, enhance scalability, and accelerate commercialization.
Key topics include:
- Strategic Foundation & Collaborative Partnerships
- Innovation & Advanced Technologies for Novel Modalities
- Future-Proofing Manufacturing: From Early Development to Commercial Scale
- Supply Chain Resilience & Operational Excellence
- Sustainability, Workforce Development & Long-Term Growth
Ecosystem Innovation
Biotech is no longer built within four walls—it’s built across global ecosystems of partners, platforms, and emerging hubs. The Ecosystem Innovation track explores how innovation is being enabled by clusters, service providers, infrastructure, and new partnership models worldwide. From next-generation incubators and rising biotech regions to the growing role of CROs, CDMOs, and data platforms as strategic partners, this track showcases how the industry is evolving beyond traditional models.
Explore the power of partnering as biotech blooms beyond the usual hubs. Key Topics include:
- Evolution of biotech hubs around the globe
- Role of next-generation incubators in fostering innovation
- Rise of emerging marketing and their impact on the industry
- New innovations in developing biotech clusters
Clinical Strategy
The Clinical Development Strategy track provides actionable strategies to streamline trial processes, navigate emerging markets, and leverage cutting-edge technologies like AI to drive efficiency and innovation. Attendees will gain insights into fostering global collaboration, building strong partnerships with CROs, funders, and innovators, and overcoming regulatory challenges to deliver impactful results. This track empowers stakeholders to expand their reach, collaborate effectively, and lead the future of clinical trials.
Sessions include:
- Expanding the Global Footprint: Opportunities and Challenges in Emerging Markets
- Mission-Driven Investments: Balancing Capital and Clinical Impact
- AI in Clinical Trials: Transforming Operations and Accelerating Development
